Lastly, BCLXL is upregulated in the tumor microenvironment of both mantle cell lymphoma and follicular lymphoma53, and the tumor microenvironment is a crucial factor in determining response to immunotherapy54. Here, BCL2L1 is linked to mantle cell lymphoma.